AVI BioPharma

Effie Toshav, J.D., has been appointed senior vice president and general counsel at AVI BioPharma, effective January 10th. Ms. Toshav has considerable industry-specific legal, corporate development and strategic experience. Most recently, she was a partner in the life sciences group at Wilson Sonsini Goodrich and Rosati (WSGR), where she served as outside counsel to a large number of prominent biotech companies advising management teams on a wide range of business and legal matters.

Prior to WSGR, she served as general counsel and a member of the management team at GlycoFi, where she was responsible for all legal and general corporate matters.

“Effie’s talent, experience and skills add considerable breadth and depth to the management team, as does her deep expertise in the key areas of corporate development and intellectual property, as we navigate this pivotal point in the company’s development,” said Chris Garabedian, AVI’s chief executive officer and president. “We are excited to have Effie join the team and look forward to her contribution.”